Polycystic kidney disease (PKD) is a debilitating hereditary condition in which fluid-filled sacs form and proliferate in the ...

A specially engineered antibody that can infiltrate kidney cysts has shown the ability to block key growth signals driving ...

A study conducted by researchers at University of California, Santa Barbara may have found a way to prevent the growth of ...

Recent market growth is driven by advancements in understanding disease mechanics, targeted therapies like tolvaptan (Jynarque), and increased diagnosis rates. Tolvaptan, approved by the FDA, marks a ...

In science, collaboration is about sharing information, resources, and ideas. The partnership allows faculty to combine their knowledge and resources to form new ideas that might not have been ...

This webinar will explore polycystic kidney disease (PKD) with a focus on autosomal dominant PKD (ADPKD), including clinical presentations, considerations for conducting clinical trials in this ...

A three-month clinical study on dietary interventions to help treat polycystic kidney disease (PKD) indicates that not only is dietary intervention feasible, it also appears to have resulted in ...

Please provide your email address to receive an email when new articles are posted on . Tolvaptan treatment correlated with a slowed annual rate of GFR decline in this population. Tolvaptan may ...

PKD is mainly caused by mutations in the PKD1 and PKD2 genes, affecting polycystin proteins. Disrupted signaling pathways, like cAMP and vasopressin, are major drivers of cyst growth. Tolvaptan is ...

March is National Kidney Month aimed at shining a spotlight on kidney health and research for kidney disease. In Raleigh, hometown Gold and Platinum musician, Jason Adamo, who's no stranger to the ...

A large two-cohort analysis published in BMC Nephrology has found that patients with autosomal dominant polycystic kidney ...